Drug Trial Radar · NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Oct 15, 2025
Primary completion
Jan 2028
Study completion Oct 2030
Sponsor
- Lead sponsor
- Nurix Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study for patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatment with a BTK inhibitor (covalent and non-covalent) and a BCL-2 inhibitor. The main purpose of this study is to test if NX-5948 (bexobrutideg) works to treat patients with CLL/SLL. Participation could last up to 5 years, and possibly longer, if the disease does not progress.
Conditions
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
Interventions
NX-5948Drug
Oral dose administered once daily. NX-5948 will be given in continuous 28-day cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate without partial response with lymphocytosis (PR-L) as determined by an Independent Review Committee (IRC)Time frame: Up to approximately 5 years
Locations
47 sites in 5 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Phoenix, Arizona · Recruiting
City of Hope
Duarte, California · Recruiting
University of California, Irvine
Irvine, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Scripps Health
San Diego, California · Recruiting
University of California, San Francisco
San Francisco, California · Recruiting
Colorado Blood Institute
Denver, Colorado · Recruiting
University of Miami
Coral Gables, Florida · Recruiting
Florida Cancer Specialists
Sarasota, Florida · Recruiting
The University of Chicago
Chicago, Illinois · Recruiting
Fort Wayne Oncology and Hematology
Fort Wayne, Indiana · Recruiting
Hematology Oncology of Indiana
Indianapolis, Indiana · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
Maryland Oncology Hematology
Silver Spring, Maryland · Recruiting
Karmanos Cancer Center
Detroit, Michigan · Recruiting
Duke University
Durham, North Carolina · Recruiting
Novant Health Cancer Institute
Winston-Salem, North Carolina · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
The Cleveland Clinic Foundation
Cleveland, Ohio · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Oncology Hematology Care
Fairfield, Ohio · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Texas Oncology - Center South
Austin, Texas · Recruiting
The University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Recruiting
Oncology & Hematology Associates of Southwest VA
Blacksburg, Virginia · Recruiting
University of Virginia Medical Center
Charlottesville, Virginia · Recruiting
Virginia Cancer Specialists, PC
Fairfax, Virginia · Recruiting
Virginia Oncology Associates
Norfolk, Virginia · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
The Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
CHU de Nantes
Nantes, France · Recruiting
Azienda Ospedaliero-Universitaria di Alessandria SS. Antonio e Biagio e Cesare Arrigo
Alessandria, Italy · Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
Bologna, Italy · Recruiting
ASST degli Spedali Civili di Brescia
Brescia, Italy · Recruiting
IRCCS - Istituto Romagnolo per lo Studio dei Tumori
Meldola (FC), Italy · Recruiting
Ospedale San Raffaele S.r.l.
Milan, Italy · Recruiting
AUSL della Romagna UO Ematologia
Ravenna, Italy · Recruiting
Pratia Hematologia Sp. z o.o.
Katowice, Poland · Recruiting
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.